Sterling Investment Advisors (Pennsylvania)’s Charles River Laboratories CRL Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-600	Closed	-$87K	–	421
2019 Q1	$87K	Hold	600	–	–	0.04%	162
2018 Q4	$67K	Hold	600	–	–	0.04%	170
2018 Q3	$81K	Hold	600	–	–	0.04%	174
2018 Q2	$67K	Sell	600 -400	-40%	-$43.2K	0.04%	173
2018 Q1	$107K	Hold	1,000	–	–	0.07%	136
2017 Q4	$109K	Hold	1,000	–	–	0.07%	137
2017 Q3	$108K	Hold	1,000	–	–	0.07%	132
2017 Q2	$101K	Hold	1,000	–	–	0.07%	135
2017 Q1	$90K	Hold	1,000	–	–	0.06%	137
2016 Q4	$76K	Buy	+1,000	New	+$75.9K	0.06%	132

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s CRL Position: Q2 2019 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Charles River Laboratories (CRL) in Q2 2019, closing a stake of 600 shares — an estimated $87K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in CRL in Q4 2016 and held it in 10 quarters. The position peaked at $109K in Q4 2017. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

Sterling Investment Advisors (Pennsylvania) reported no remaining Charles River Laboratories position as of Q2 2019 after selling out during the quarter.
Sterling Investment Advisors (Pennsylvania) sold 600 Charles River Laboratories shares in Q2 2019, an estimated $87K.
Sterling Investment Advisors (Pennsylvania) first reported a position in Charles River Laboratories in Q4 2016 and held it in 10 quarters.
Sterling Investment Advisors (Pennsylvania)'s Charles River Laboratories position peaked at $109K in Q4 2017.
405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2019, filed 6 Aug 2019.